Market Overview:
The global pharmaceutical grade nicotinamide market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for nicotinamide from the tissue culture medium and drug applications segments. Additionally, rising awareness about the benefits of nicotinamide is also contributing to the growth of this market. However, stringent regulatory norms could hamper the growth of this market in some regions during the forecast period. On basis on type, USP grade accounted for majority share in 2017 and is projected to maintain its dominance throughout forecast period owing high adoption rate by end users across globe followed by EP grade .
Product Definition:
A pharmaceutical grade nicotinamide is a form of vitamin B3 that has been purified and is free from impurities. It is used in the treatment of a variety of conditions, including skin conditions, diabetes, and high cholesterol.
USP:
Usp is a chemical compound naturally found in the body and can be manufactured by the liver. It plays an important role in maintaining healthy cells, especially those of the immune system. Nicotinamide (NAM) is used to treat a variety of diseases and infections such as viral warts, chickenpox, shingles (herpes zoster), cold sores, foot & mouth disease; bladder infection; malaria; gum disease & periodontitis among others.
EP:
Nicotinamide, also known as N-3-methylpyrrolidinium or 2-oxopyrrolidinium is a chemical compound. It is an amide derived from pyrrolidine and has been used in medicine as well as in other commercial products such as cosmetics. Nicotinamide (NAM) has gained significant importance owing to its biological activity and use in the treatment of several diseases including cardiovascular, cancer & diabetes.
Application Insights:
Drugs were the major application segment and accounted for more than 70.0% share of the global pharmaceutical grade nicotinamide market in 2017. The drugs application includes tissue culture medium, which is used for growing cells and tissues under laboratory conditions. Nicotinamide plays a vital role in cell metabolism by providing necessary nutrients to the cell including nitrogen, sulfur, oxygen, calcium and phosphorus. Thus it has gained importance as a drug nutrient throughout history owing to its ability to modulate multiple cellular functions thereby improving health outcomes across various diseases such as cancer & diabetes mellitus type II & cardiovascular disease (CVD).
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is anticipated to witness significant growth over the forecast period owing to rising demand for generic drugs. The region accounts for a major share of global pharmaceutical grade niacinamide market by application tissue culture medium. This can be attributed to factors such as increasing research & development activities, growing biotechnology industry, and presence of key manufacturers in countries such as China, India, South Korea & Japan.
The Asia Pacific has been witnessing strong economic growth since 2010 with emerging economies like China and India playing a crucial role in this process. In addition, favorable government policies aimed at promoting R&D are expected to drive the regional market over the forecast period.
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is expected to drive the demand for pharmaceutical grade nicotinamide over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth owing to increasing incidence of age-related health conditions that require treatment with nicotinamide.
- Growing awareness about the benefits of nicotinamide in prevention and treatment of various chronic diseases is projected to propel its demand in coming years.
- Technological advancements in drug delivery systems are likely to provide lucrative opportunities for market players over the forecast period. 5) Stringent regulatory framework pertaining to quality and safety standards for pharmaceutical grade nicotinamide is expected to create new opportunities for market players over the next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Nicotinamide Market Research Report
By Type
USP, EP, Other
By Application
Tissue Culture Medium, Drugs
By Companies
Lonza, Jubilant Life Sciences, Vertellus, Brother Enterprises, Zhejiang Lanbo Biotechnology, Lasons India, Vanetta, DSM
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Nicotinamide Market Report Segments:
The global Pharmaceutical Grade Nicotinamide market is segmented on the basis of:
Types
USP, EP, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tissue Culture Medium, Drugs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Jubilant Life Sciences
- Vertellus
- Brother Enterprises
- Zhejiang Lanbo Biotechnology
- Lasons India
- Vanetta
- DSM
Highlights of The Pharmaceutical Grade Nicotinamide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- USP
- EP
- Other
- By Application:
- Tissue Culture Medium
- Drugs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Nicotinamide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical grade nicotinamide is a form of vitamin B3 that is used in supplements and medications. It is considered to be more effective than other forms of the vitamin, and it has been shown to help improve cognitive function and reduce the risk of Alzheimer's disease.
Some of the major players in the pharmaceutical grade nicotinamide market are Lonza, Jubilant Life Sciences, Vertellus, Brother Enterprises, Zhejiang Lanbo Biotechnology, Lasons India, Vanetta, DSM.
The pharmaceutical grade nicotinamide market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Grade Nicotinamide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Grade Nicotinamide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Grade Nicotinamide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Grade Nicotinamide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Grade Nicotinamide Market Size & Forecast, 2020-2028
4.5.1 Pharmaceutical Grade Nicotinamide Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Grade Nicotinamide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 USP
5.2.2 EP
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tissue Culture Medium
6.2.2 Drugs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Grade Nicotinamide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Grade Nicotinamide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 USP
9.6.2 EP
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tissue Culture Medium
9.10.2 Drugs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 USP
10.6.2 EP
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tissue Culture Medium
10.10.2 Drugs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 USP
11.6.2 EP
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tissue Culture Medium
11.10.2 Drugs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 USP
12.6.2 EP
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tissue Culture Medium
12.10.2 Drugs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 USP
13.6.2 EP
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tissue Culture Medium
13.10.2 Drugs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Grade Nicotinamide Market: Competitive Dashboard
14.2 Global Pharmaceutical Grade Nicotinamide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Jubilant Life Sciences
14.3.3 Vertellus
14.3.4 Brother Enterprises
14.3.5 Zhejiang Lanbo Biotechnology
14.3.6 Lasons India
14.3.7 Vanetta
14.3.8 DSM
